Literature DB >> 28867451

Postprandial triglyceride responses and endothelial function in prediabetic first-degree relatives of patients with diabetes.

Srivenkata Madhu1, Bineet Sinha2, Mohammad Aslam3, Gopesh Mehrotra4, Shridhar Dwivedi5.   

Abstract

BACKGROUND: Only a few studies have reported on postprandial lipid responses and endothelial function in prediabetic subjects. None of the study has compared role of familial predisposition in determining postprandial endothelial dysfunction and postprandial hypertriglyceridemia in subjects with prediabetes.
OBJECTIVE: The objective was to study the postprandial triglyceride (PPTG) responses and endothelial function in prediabetic first-degree relatives of patients with diabetes.
METHODS: Thirty-nine subjects were recruited on the basis of oral glucose tolerance test into 3 groups: group 1, prediabetic subjects who had a first-degree relative with diabetes; group 2, prediabetic subjects without family history of diabetes; and group 3, normal glucose tolerance subjects without family history of diabetes. Oral fat challenge test was performed in all study subjects and PPTG responses were measured up to 8 hours. Postprandial endothelial function after 4 hours of fat challenge was estimated by flow-mediated dilation.
RESULTS: Postprandial endothelial dysfunction was greatest in group 1 and significantly higher in group 1 compared with group 2 (P < .001) and group 2 compared with group 3 (P < .001). PPTG responses (TG-AUC, TG-peak, TG-6 hour, and TG-8 hour) were significantly higher in group 1 compared with groups 2 and 3. However, they were similar between groups 2 and 3. Endothelial function showed significant negative correlation with TG-6 hour and TG-8 hour.
CONCLUSION: Prediabetic subjects respond to fat challenge with a greater degree of TG response and endothelial dysfunction compared with normal glucose tolerance subjects especially if they have a first-degree relative with diabetes. This may contribute to enhanced cardiovascular risk reported in prediabetic individuals.
Copyright © 2017 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dyslipidemia; Endothelial dysfunction; Family history; Postprandial triglycerides; Prediabetes

Mesh:

Substances:

Year:  2017        PMID: 28867451     DOI: 10.1016/j.jacl.2017.08.001

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  6 in total

1.  Chitosan-Encapsulated Nano-selenium Targeting TCF7L2, PPARγ, and CAPN10 Genes in Diabetic Rats.

Authors:  Omayma A R Abozaid; Sawsan M El-Sonbaty; Neama M A Hamam; Moustafa A Farrag; Ahmad S Kodous
Journal:  Biol Trace Elem Res       Date:  2022-03-02       Impact factor: 3.738

2.  Identification of the Chinese Population That Can Benefit Most From Postprandial Lipid Testing: Validation of the Use of Oral Fat Tolerance Testing in Clinical Practice.

Authors:  Xiaoyu Hou; An Song; Yunpeng Guan; Peipei Tian; Luping Ren; Yong Tang; Chao Wang; Ling Gao; Guangyao Song; Xiaoping Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-18       Impact factor: 5.555

Review 3.  Molecular mechanisms underlying some major common risk factors of stroke.

Authors:  Reem Alkahtani
Journal:  Heliyon       Date:  2022-08-18

4.  TCF7L2 gene associated postprandial triglyceride dysmetabolism- a novel mechanism for diabetes risk among Asian Indians.

Authors:  Sri Venkata Madhu; Brijesh Kumar Mishra; Velmurugan Mannar; Mohd Aslam; Basudev Banerjee; Vivek Agrawal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-03       Impact factor: 6.055

5.  Association of PPARγ gene expression with postprandial hypertriglyceridaemia and risk of type 2 diabetes mellitus.

Authors:  B K Mishra; B D Banerjee; V Agrawal; S V Madhu
Journal:  Endocrine       Date:  2020-03-16       Impact factor: 3.633

6.  Human postprandial responses to food and potential for precision nutrition.

Authors:  Sarah E Berry; Ana M Valdes; Nicola Segata; Paul W Franks; Tim D Spector; David A Drew; Francesco Asnicar; Mohsen Mazidi; Jonathan Wolf; Joan Capdevila; George Hadjigeorgiou; Richard Davies; Haya Al Khatib; Christopher Bonnett; Sajaysurya Ganesh; Elco Bakker; Deborah Hart; Massimo Mangino; Jordi Merino; Inbar Linenberg; Patrick Wyatt; Jose M Ordovas; Christopher D Gardner; Linda M Delahanty; Andrew T Chan
Journal:  Nat Med       Date:  2020-06-11       Impact factor: 53.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.